Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 629
interventional 493
Observational 125
Registry 11

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 157
Drug|placebo 149
Other 40
Biological 29
Device 20
Biological|placebo 17
Behavioral 13
Procedure 12
Dietary Supplement 8
Dietary Supplement|placebo 7
Other|placebo 4
Biological|Other 3
Biological|Procedure 3
Device|Procedure 3
Dietary Supplement|Drug 3
Drug|Other 3
Drug|Procedure 3
Biological|Drug 2
Diagnostic Test 2
Drug|Other|placebo 2
Drug|placebo|Procedure 2
Behavioral|Other 1
Biological|Diagnostic Test|Drug 1
Biological|Drug|placebo 1
Device|Drug 1
Device|Other 1
Device|placebo 1
Diagnostic Test|Drug 1
Diagnostic Test|Drug|Other 1
Dietary Supplement|Other 1
Drug|Genetic 1
Drug|Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 105
NA 26
Germany 22
Canada 18
France 18
China 17
Denmark 17
United Kingdom 15
Japan 13
Israel 10
Netherlands 9
United States|Canada 7
Italy 6
Belgium 5
Spain 5
Sweden 5
United States|Canada|Puerto Rico 5
Australia 4
Korea, Republic of 4
Hong Kong 3
India 3
Norway 3
Switzerland 3
Austria|Belarus|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Serbia|Slovakia|Slovenia|Spain|Ukraine|United Kingdom 2
Germany|Sweden 2
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 2
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Switzerland|Turkey|Ukraine|United Kingdom 2
United States|Argentina|Australia|Austria|Belgium|Canada|China|Croatia|Czechia|Denmark|France|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 2
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain 2
United States|Bulgaria|Canada|Hungary|Latvia|Mexico|Poland|Russian Federation|Serbia|Switzerland|Ukraine 2
United States|Bulgaria|Georgia|Germany|Greece|Hungary|Ireland|Israel|Italy|Moldova, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 2
Argentina|Belgium|Brazil|Canada|Chile|Czech Republic|Estonia|Hungary|Italy|Russian Federation|Singapore|South Africa|Spain|Sweden 1
Australia|Belgium|Czech Republic|Denmark|France|Germany|Hungary|Israel|Italy|Poland|Russian Federation|South Africa|Spain|Sweden|United Kingdom 1
Australia|Belgium|Estonia|France|Israel|Italy|Latvia|Lithuania|Poland|Romania|Russian Federation|Slovakia|Sweden|Ukraine|United Kingdom 1
Australia|Bulgaria|Czechia|Estonia|Hungary|India|Italy|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Romania|Russian Federation|Serbia|South Africa|Turkey|Ukraine 1
Australia|China|Korea, Republic of|Taiwan 1
Austria 1
Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Norway|Portugal|Romania|Singapore|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Netherlands 1
Austria|Belgium|France|Israel|Italy|Netherlands 1
Belarus|India|Turkey|Ukraine 1
Belgium|Brazil|Chile|Czech Republic|Denmark|France|Hungary|Israel|Italy|Mexico|Netherlands|Poland|Slovakia|South Africa|Spain|Sweden|United Kingdom 1
Belgium|Canada|Germany|Norway|Sweden 1
Belgium|Czech Republic|Denmark|Finland|Germany|Netherlands|Norway|Sweden 1
Belgium|Czech Republic|Denmark|Germany|Norway|Slovakia|Spain 1
Belgium|Czech Republic|Germany|Hungary|Poland|Russian Federation 1
Belgium|Czech Republic|Latvia|Slovakia 1
Belgium|Finland|France|Italy|Spain 1
Belgium|France 1
Belgium|France|Netherlands|United Kingdom 1
Belgium|Germany|United Kingdom 1
Belgium|Hungary|Netherlands 1
Belgium|Hungary|Slovakia|Spain 1
Belgium|Poland|Spain|United Kingdom 1
Belgium|United States|Argentina|Austria|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Bulgaria|Czechia|Hungary|Latvia|Lithuania|Poland|Ukraine|United Kingdom 1
Bulgaria|Hungary|Poland 1
Bulgaria|United States|Argentina|Australia|Brazil|Colombia|Croatia|Czechia|Greece|Hungary|Latvia|Lithuania|Malaysia|New Zealand|Poland|Russian Federation|Turkey|Ukraine 1
Canada|Belgium|Netherlands|Sweden 1
Canada|Finland|Israel|Italy|Poland|Spain 1
Canada|Sweden|Ukraine|United States|Australia|Austria|Belgium|Bulgaria|Czech Republic|Denmark|France|Germany|Hungary|India|Israel|Japan|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa 1
Canada|United States|Australia|Belgium|Brazil|Czech Republic|France|Germany|India|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|South Africa|Switzerland|United Kingdom 1
Czech Republic|France|Germany|Italy|Poland|United Kingdom 1
Czech Republic|Italy 1
Czechia 1
Czechia|France|Germany|Hungary|Italy|Poland|United Kingdom 1
Czechia|Netherlands|Poland 1
Denmark|Germany|Netherlands|Norway|Spain|United Kingdom 1
Denmark|Korea, Republic of|United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
Finland 1
France|Greece|Israel|Italy|Korea, Republic of|Serbia 1
France|Israel|Italy 1
France|United States|Belgium|Canada|Colombia|Czechia|Germany|Hungary|India|Ireland|Poland|Romania|South Africa|Spain|United Kingdom 1
Georgia|Germany|Moldova, Republic of|Ukraine 1
Georgia|Moldova, Republic of|Ukraine 1
Germany|Hungary|United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|France|Iceland|Ireland|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|South Africa|Spain|United Kingdom 1
Germany|Israel|Netherlands|Singapore|Sweden|Switzerland|United Kingdom 1
Germany|United Kingdom 1
Hungary 1
Hungary|United States|Australia|Belgium|Brazil|Bulgaria|Canada|Croatia|France|Germany|Iceland|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|South Africa|Spain|United Kingdom 1
India|United States|Australia|Austria|Belgium|Bulgaria|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|Japan|Latvia|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Sweden|Ukraine 1
Ireland 1
Ireland|United Kingdom 1
Israel|Netherlands|Denmark|France|Germany|United States|Austria|Belgium|Canada|Poland 1
Israel|Slovakia|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Israel|Spain 1
Israel|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Italy|Lithuania|Poland|Russian Federation 1
Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Jordan 1
Lebanon 1
Mexico 1
Netherlands|United Kingdom 1
Poland|United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|New Zealand|Norway|Portugal|Spain|Switzerland 1
Portugal 1
Ukraine|Czechia|France|Germany|Hungary|Poland|Russian Federation|Serbia|Spain|Sweden 1
Ukraine|United States|Australia|Belgium|Bulgaria|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Romania|Russian Federation 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|India|Greece|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom|Vietnam 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Greece|Hungary|United Kingdom|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Spain|Switzerland 1
United States|Argentina|Australia|Austria|Belgium|Canada|Croatia|Czechia|Denmark|France|Georgia|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Moldova, Republic of|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|France|Germany|Hungary|India|Korea, Republic of|Mexico|Netherlands|New Zealand|Peru|Poland|Portugal|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Australia|Brazil|Bulgaria|Estonia|France|Hong Kong|Mexico|Poland|Russian Federation|Serbia|Slovakia|Ukraine 1
United States|Argentina|Australia|Brazil|Germany|Mexico|Poland|Russian Federation|Ukraine 1
United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Sweden|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Estonia|Greece|Hungary|Ireland|Japan|Korea, Republic of|Lebanon|Mexico|New Zealand|Portugal|Slovakia|Spain|Switzerland|Turkey|Ukraine 1
United States|Australia 1
United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Hungary|Italy|Mexico|Netherlands|Poland|South Africa 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Lithuania|New Zealand|Poland|Romania|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Latvia|Lithuania|New Zealand|Poland|Romania|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Italy|Latvia|Netherlands|Norway|Poland|Russian Federation|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Hungary|Israel|Japan|New Zealand|Poland|Slovakia|Spain|United Kingdom 1
United States|Australia|Austria|Brazil|Croatia|Czechia|Germany|Israel|Italy|Japan|Lithuania|Netherlands|Poland|Romania|Russian Federation|Serbia|South Africa|United Kingdom 1
United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|Estonia|France|Georgia|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Moldova, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Estonia|Georgia|Hungary|India|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine 1
United States|Australia|Belgium|Bulgaria|Canada|Greece|Hungary|Israel|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Slovakia|Ukraine 1
United States|Australia|Belgium|Canada|Czech Republic|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|France|Georgia|Hungary|Japan|Lithuania|Moldova, Republic of|Netherlands|Poland|Romania|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Poland|Russian Federation|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|Korea, Republic of|Malaysia 1
United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Germany|Israel|Italy|Korea, Republic of|Saudi Arabia|Serbia|Spain|Turkey 1
United States|Australia|Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Netherlands|New Zealand|Poland|Russian Federation|Ukraine 1
United States|Australia|Bulgaria|Canada|France|Georgia|Germany|Greece|Hungary|Israel|Japan|Korea, Republic of|Poland|Portugal|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine 1
United States|Australia|Bulgaria|Hungary|Italy|Japan|Poland|Russian Federation|Slovakia|Spain|Thailand|Turkey 1
United States|Australia|Poland|Slovakia|United Kingdom 1
United States|Austria|Belgium|Canada|Czech Republic|Germany|Hungary|Italy|Netherlands|Poland|Puerto Rico|Slovakia|Sweden 1
United States|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Netherlands|Poland|Romania|Slovakia|Spain|Switzerland|Ukraine|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Greece|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom 1
United States|Austria|Bulgaria|Canada|Czechia|Denmark|Georgia|Germany|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Turkey|Ukraine 1
United States|Austria|Bulgaria|Canada|France|Germany|Hungary|Netherlands|Poland|Romania|Spain 1
United States|Belarus|Bosnia and Herzegovina|Bulgaria|Croatia|Czechia|Netherlands|North Macedonia|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 1
United States|Belarus|Bosnia and Herzegovina|Croatia|Georgia|Hungary|Moldova, Republic of|Poland|Russian Federation|Serbia|Ukraine 1
United States|Belarus|Bulgaria|Canada|France|Germany|Hungary|Ireland|Israel|Italy|Poland|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 1
United States|Belarus|Canada|Croatia|Czech Republic|Estonia|Hungary|Latvia|Lithuania|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Ukraine 1
United States|Belgium|Brazil|France|Israel|Italy|Korea, Republic of|Netherlands|Poland|Spain|Taiwan 1
United States|Belgium|Bulgaria|Canada|Czech Republic|France|Germany|Hungary|Netherlands|Poland|Russian Federation|Ukraine 1
United States|Belgium|Canada 1
United States|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Belgium|Canada|Denmark|Netherlands 1
United States|Belgium|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|France|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|Germany|Hungary|Italy|Slovakia|Sweden 1
United States|Belgium|Canada|Germany|Netherlands|United Kingdom 1
United States|Belgium|Canada|Hungary 1
United States|Belgium|Canada|Hungary|Moldova, Republic of|Netherlands|Romania 1
United States|Belgium|Czech Republic|India|Poland|Russian Federation|Slovakia|Ukraine|United Kingdom 1
United States|Belgium|Italy|Korea, Republic of|Netherlands|Poland 1
United States|Brazil|Canada|Czechia|Denmark|Germany|Hungary|India|Israel|Italy|Mexico|Poland|Slovakia|South Africa|Ukraine 1
United States|Bulgaria|Canada|Czechia|Estonia|France|India|Korea, Republic of|Netherlands|Poland|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom 1
United States|Bulgaria|Canada|Czechia|Estonia|Hungary|Latvia|Lithuania|Poland|Russian Federation|Ukraine 1
United States|Bulgaria|Canada|Hungary|Poland|Slovakia 1
United States|Canada|Croatia|Poland|Romania 1
United States|Canada|Czech Republic|Hungary|Latvia|Romania|Russian Federation|Ukraine 1
United States|Canada|Czech Republic|Hungary|Poland|Russian Federation|Slovakia 1
United States|Canada|Czechia|Hungary|Netherlands|Poland|Serbia 1
United States|Canada|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Canada|Hungary|Israel|Poland|Slovakia|United Kingdom 1
United States|Canada|India|Mexico 1
United States|Canada|Israel 1
United States|Canada|Israel|Japan|Korea, Republic of 1
United States|Canada|Puerto Rico|United Kingdom 1
United States|China 1
United States|China|Poland|Puerto Rico|Ukraine 1
United States|Czechia|Hungary 1
United States|Czechia|Hungary|Poland|Romania|Russian Federation|Serbia 1
United States|Denmark|Finland|Ireland|Israel|Slovenia|United Kingdom 1
United States|Denmark|Germany|Poland 1
United States|Georgia|Hungary|Moldova, Republic of|Ukraine 1
United States|Georgia|Moldova, Republic of 1
United States|Germany 1
United States|Germany|Netherlands|Poland|Russian Federation|Sweden|United Kingdom 1
United States|Japan|Poland|Slovakia|Spain|United Kingdom 1
United States|Lithuania|Poland|Slovakia 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 222
2 22
3 14
4 6
5 9
6 4
7 9
8 7
9 3
10 1
11 4
12 4
13 3
14 2
15 3
16 5
17 1
18 3
19 6
20 4
22 4
23 4
24 2
25 2
26 2
27 2
28 4
29 1
30 3
31 2
33 5
34 2
35 1
36 2
37 2
38 1
39 1
40 1
41 2
42 1
43 1
44 1
45 3
47 1
50 1
51 1
52 2
55 1
57 1
58 2
59 2
60 2
61 1
62 2
64 3
65 1
66 2
68 1
69 1
71 2
72 2
75 1
76 1
77 1
78 1
80 1
82 1
86 1
88 3
89 1
90 1
92 1
93 1
94 1
95 1
96 1
97 1
99 3
102 1
104 1
105 5
108 2
111 1
114 1
115 1
117 1
119 1
120 1
123 1
125 1
126 1
134 1
135 1
136 1
140 1
142 1
144 1
150 1
166 1
173 2
174 1
178 1
182 1
190 1
195 1
207 1
208 1
210 1
220 1
224 1
245 2
253 1
262 1
275 1
298 1
305 1
307 1
309 1
323 1
330 1
343 1
372 2
378 1
382 1
409 1
433 1
435 1
463 1
516 1
524 1
586 1
590 1
855 1

Phase

Phase Study_Count
Phase 2 129
Phase 3 128
N/A 103
Phase 1 56
Phase 4 44
Phase 1/Phase 2 15
Phase 2/Phase 3 14
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 95
2 222
3 67
4 24
5 19
6 7
7 1
8 3
10 4
12 1
14 1
16 1
NA 48

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 12 4.0 3.00000 3.00000 1.0000 15.0000 13.0000 1.0000
1st Qu. 12 31.5 19.50000 15.50000 45.0000 47.5000 140.0000 41.0000
Median 16 72.0 31.00000 34.00000 100.0000 109.0000 358.0000 119.5000
Mean 26 980514.9 40.10714 56.46667 119.2362 346.0714 473.6142 166.8409
3rd Qu. 30 148.5 49.25000 55.00000 179.5000 665.0000 644.0000 201.2500
Max. 60 99999999.0 181.00000 300.00000 375.0000 1065.0000 3384.0000 759.0000

Trial Group Type

group_type Group_Count
Experimental 649
Placebo Comparator 206
Active Comparator 151
Other 58
NA 48
No Intervention 14
Sham Comparator 8

Intervention Model

intervention_model Study_Count
Parallel Assignment 351
Single Group Assignment 117
Crossover Assignment 14
NA 6
Sequential Assignment 4
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 390
Diagnostic 21
Prevention 20
Basic Science 15
Other 15
Supportive Care 14
NA 10
Health Services Research 5
Screening 3

Observational Studies

Studies by Country

Country Study_Count
United States 35
NA 10
Korea, Republic of 8
France 7
Canada 6
United Kingdom 5
United States|Canada 5
China 4
Japan 4
Belgium 3
Denmark 3
Germany 3
Italy 3
Netherlands 3
Austria 2
Czech Republic 2
Spain 2
Sweden 2
Australia 1
Brazil 1
Canada|Germany|Ireland|Italy|Netherlands|Poland|Sweden|United Kingdom 1
Croatia 1
Denmark|France|United States|Argentina|Australia|Austria|Belgium|Canada|Czechia|Germany|Israel|Netherlands|New Zealand|Switzerland|United Kingdom 1
Greece 1
Hong Kong|Singapore|Taiwan 1
Israel 1
Norway 1
Portugal 1
Romania 1
Russian Federation 1
Saudi Arabia 1
Switzerland 1
Taiwan|Argentina|China|Colombia|Korea, Republic of|Mexico|Russian Federation|Saudi Arabia|Singapore|Turkey 1
United States|Australia|Austria|Belgium|Canada|Croatia|Denmark|France|Germany|Greece|Ireland|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Puerto Rico|Spain|Sweden|United Kingdom 1
United States|Austria|Belgium|Canada|Croatia|Denmark|Estonia|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Canada|Czechia|France|Germany|Greece|Italy|Korea, Republic of|Spain 1

Sites per Study

Site_count Study_Count
1 85
2 7
3 1
4 3
6 2
7 1
8 1
12 1
13 1
15 3
18 1
19 1
21 1
23 1
24 1
26 1
30 2
41 1
61 1
63 1
76 1
80 1
103 1
105 1
108 1
149 1
159 1
287 1
515 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 60.000
Median 150.000
Mean 710.032
3rd Qu 381.000
Max 20000.000

Observation Model

observational_model Study_Count
Cohort 77
Case-Only 20
Case-Control 11
Case Control 6
NA 5
Other 4
Case-Crossover 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 97
Retrospective 14
Cross-Sectional 10
Other 3
NA 1

Registries

Studies by Country

Country Study_Count
United States 3
Netherlands 2
Canada 1
Czechia 1
Germany 1
Israel 1
Italy 1
Spain 1

Sites per Study

Site_count Study_Count
1 8
3 1
13 1
37 1

Enrollment Metrics

Measure Registries
Min 100.000
1st Qu 340.000
Median 480.000
Mean 2242.182
3rd Qu 1150.000
Max 15000.000

Registry Model

observational_model Study_Count
Cohort 11

Time Perspective

time_perspective Study_Count
Prospective 9
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
5 Years 4
1 Year 2
1 Day 1
2 Weeks 1
2 Years 1
25 Years 1
3 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03268213 Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis https://ClinicalTrials.gov/show/NCT03268213 Active, not recruiting Stony Brook University 2022-06-30
NCT02531126 Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02531126 Active, not recruiting Celgene 2022-02-28
NCT04277546 Open-label Extension Study of Brazikumab in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04277546 Enrolling by invitation Allergan 2023-04-12
NCT02365480 Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission https://ClinicalTrials.gov/show/NCT02365480 Active, not recruiting National Cancer Institute (NCI) 2018-02-16
NCT03138655 Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn’s Disease (CD) https://ClinicalTrials.gov/show/NCT03138655 Completed Takeda 2020-03-31
NCT04090411 A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04090411 Recruiting Pfizer 2023-10-24
NCT04033445 A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04033445 Recruiting Janssen Research & Development, LLC 2022-06-29
NCT04004611 A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT04004611 Recruiting Eli Lilly and Company 2022-07-21
NCT03950232 An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03950232 Recruiting Arena Pharmaceuticals 2024-10-31
NCT03662542 A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03662542 Recruiting Janssen Research & Development, LLC 2020-11-17
NCT03648541 BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03648541 Recruiting Boehringer Ingelheim 2031-03-30
NCT03596645 A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03596645 Recruiting Janssen Research & Development, LLC 2021-12-22
NCT03524092 A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03524092 Recruiting Eli Lilly and Company 2021-03-16
NCT03519945 A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) https://ClinicalTrials.gov/show/NCT03519945 Recruiting Eli Lilly and Company 2023-08-23
NCT03518086 An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) https://ClinicalTrials.gov/show/NCT03518086 Recruiting Eli Lilly and Company 2020-09-07
NCT03378167 PediCRaFT: Pediatric Crohn’s Disease Fecal Transplant Trial https://ClinicalTrials.gov/show/NCT03378167 Recruiting McMaster Children’s Hospital 2021-07-31
NCT02822352 RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis https://ClinicalTrials.gov/show/NCT02822352 Completed Portsmouth Hospitals NHS Trust 2018-03-08
NCT00336492 A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00336492 Completed Centocor, Inc. 2009-05-31
NCT04176588 A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04176588 Recruiting Everstar Therapeutics Limited 2022-10-31
NCT03937609 TITRATE (inducTIon for acuTe ulceRATivE Colitis) https://ClinicalTrials.gov/show/NCT03937609 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2023-12-31
NCT02606032 Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02606032 Recruiting Hamilton Health Sciences Corporation 2019-12-31
NCT03945188 Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03945188 Recruiting Arena Pharmaceuticals 2021-11-30
NCT03482635 BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03482635 Completed Boehringer Ingelheim 2020-05-18
NCT03462459 Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection https://ClinicalTrials.gov/show/NCT03462459 Recruiting University of Wisconsin, Madison 2021-12-31
NCT01045018 A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01045018 Completed EMET Pharmaceuticals, LLC 2009-06-30
NCT01036022 Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01036022 Completed GlaxoSmithKline 2013-01-10
NCT00889161 Curcumin in Pediatric Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00889161 Completed Seattle Children’s Hospital 2010-06-30
NCT01465763 A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01465763 Completed Pfizer 2015-05-31
NCT03341962 Phase 2 Dose-finding IMU-838 for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03341962 Recruiting Immunic AG 2022-07-10
NCT03301311 Personalized Research on Diet in Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT03301311 Active, not recruiting Children’s Hospital Medical Center, Cincinnati 2020-12-02
NCT03290781 An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03290781 Recruiting Shire 2024-06-15
NCT03298022 Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03298022 Recruiting AbGenomics International, Inc. 2020-04-30
NCT03281304 A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission https://ClinicalTrials.gov/show/NCT03281304 Active, not recruiting Pfizer 2020-02-14
NCT03283085 A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn’s Disease (AIDA) https://ClinicalTrials.gov/show/NCT03283085 Recruiting Shire 2025-02-11
NCT03275467 Faecal Microbiota Transplantation in Patients With Microscopic Colitis https://ClinicalTrials.gov/show/NCT03275467 Completed Örebro University, Sweden 2019-06-05
NCT03269695 Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. https://ClinicalTrials.gov/show/NCT03269695 Recruiting Pfizer 2021-07-27
NCT02463305 Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT02463305 Recruiting University of Colorado, Denver 2020-12-31
NCT03221036 Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03221036 Recruiting Takeda 2022-05-16
NCT03209232 Infliximab Accelerated Induction in Moderate to Severe Pediatric UC https://ClinicalTrials.gov/show/NCT03209232 Recruiting Schneider Children’s Medical Center, Israel 2021-12-31
NCT03196427 Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn’s Disease (CD) https://ClinicalTrials.gov/show/NCT03196427 Active, not recruiting Takeda 2021-01-03
NCT03182166 Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization https://ClinicalTrials.gov/show/NCT03182166 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2020-10-30
NCT03178669 The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03178669 Active, not recruiting InDex Pharmaceuticals 2019-09-30
NCT03172195 Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up https://ClinicalTrials.gov/show/NCT03172195 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2021-06-30
NCT03259334 Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03259334 Active, not recruiting Shire 2024-07-12
NCT03122613 Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03122613 Recruiting Chinese University of Hong Kong 2020-04-30
NCT03259308 Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03259308 Active, not recruiting Shire 2024-07-12
NCT03103412 TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03103412 Completed Theravance Biopharma 2017-11-08
NCT03101800 Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03101800 Recruiting Hvidovre University Hospital 2019-11-14
NCT03093259 ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03093259 Completed Abivax S.A. 2018-06-30
NCT03091309 Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03091309 Recruiting Mount Sinai Hospital, Canada 2020-10-01
NCT03235752 Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03235752 Recruiting I-Mab Biopharma HongKong Limited 2020-12-26
NCT03011268 Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? https://ClinicalTrials.gov/show/NCT03011268 Recruiting Helse Møre og Romsdal HF 2021-12-31
NCT03006809 Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03006809 Recruiting University of California, San Francisco 2020-12-31
NCT03000101 Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03000101 Active, not recruiting Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 2020-07-31
NCT02994836 GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) https://ClinicalTrials.gov/show/NCT02994836 Recruiting Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 2021-12-31
NCT02985593 A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02985593 Completed Kyowa Kirin Co., Ltd. 2017-12-26
NCT02958865 Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02958865 Recruiting Pfizer 2020-12-06
NCT02163759 A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1) https://ClinicalTrials.gov/show/NCT02163759 Completed Hoffmann-La Roche 2020-02-19
NCT02922881 Microbiota-targeted Diet for Pediatric UC https://ClinicalTrials.gov/show/NCT02922881 Recruiting Children’s Hospital of Philadelphia 2020-07-31
NCT02914535 Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02914535 Active, not recruiting Gilead Sciences 2023-11-30
NCT02914522 Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02914522 Completed Gilead Sciences 2020-03-31
NCT02910245 Mercaptopurine Therapy in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02910245 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2022-04-30
NCT02903966 GSK2982772 Study in Subjects With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02903966 Completed GlaxoSmithKline 2019-06-17
NCT02100696 A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors https://ClinicalTrials.gov/show/NCT02100696 Completed Hoffmann-La Roche 2020-04-16
NCT02888379 Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02888379 Completed Topivert Pharma Ltd 2017-06-28
NCT02883452 A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn’s Disease and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02883452 Completed Celltrion 2019-02-04
NCT02878083 Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT) https://ClinicalTrials.gov/show/NCT02878083 Recruiting Nantes University Hospital 2019-07-31
NCT02862132 Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT02862132 Recruiting Shaare Zedek Medical Center 2020-07-31
NCT02840721 Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT02840721 Completed Pfizer 2018-05-31
NCT02825914 CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM) https://ClinicalTrials.gov/show/NCT02825914 Completed University of Aarhus 2019-07-01
NCT02818543 Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02818543 Completed Lycera Corp. 2016-06-30
NCT01340872 Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) https://ClinicalTrials.gov/show/NCT01340872 Completed Shield Therapeutics 2013-10-31
NCT02762500 An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02762500 Completed Lycera Corp. 2018-05-31
NCT02749630 A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn’s Disease (CD) https://ClinicalTrials.gov/show/NCT02749630 Completed Genentech, Inc. 2020-02-19
NCT02748590 Evaluation of Sacral Neuromodulation (SNM) in the Treatment of Active Ulcerative Colitis (PRIMICISTIM) https://ClinicalTrials.gov/show/NCT02748590 Completed Nantes University Hospital 2020-01-31
NCT02743806 Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT02743806 Active, not recruiting Takeda 2022-02-15
NCT02734589 Fecal Transplantation Using a Diet for Donor and Recipient in Refractory Colitis https://ClinicalTrials.gov/show/NCT02734589 Recruiting Wolfson Medical Center 2020-04-30
NCT02687724 Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis https://ClinicalTrials.gov/show/NCT02687724 Recruiting University College Dublin 2020-02-29
NCT02665845 Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis). https://ClinicalTrials.gov/show/NCT02665845 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2021-09-30
NCT02647866 Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02647866 Completed Kyowa Kirin Pharmaceutical Development, Inc. 2018-09-30
NCT02646657 An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02646657 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2021-12-31
NCT02632175 Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02632175 Active, not recruiting AbbVie 2025-03-05
NCT02622139 Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD) https://ClinicalTrials.gov/show/NCT02622139 Completed University of Erlangen-Nürnberg Medical School 2017-10-31
NCT02620046 Vedolizumab Subcutaneous Long-Term Open-Label Extension Study https://ClinicalTrials.gov/show/NCT02620046 Active, not recruiting Takeda 2021-08-11
NCT02618187 A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02618187 Completed Seres Therapeutics, Inc. 2017-12-06
NCT02611830 Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02611830 Completed Takeda 2018-05-30
NCT02589665 A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02589665 Completed Eli Lilly and Company 2017-12-19
NCT03616821 An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION] https://ClinicalTrials.gov/show/NCT03616821 Recruiting Allergan 2020-08-30
NCT03029143 Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03029143 Active, not recruiting Takeda 2020-07-15
NCT02819635 A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02819635 Recruiting AbbVie 2021-10-07
NCT02569333 Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02569333 Completed Mount Sinai Hospital, Canada 2019-01-31
NCT02559713 Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn’s Disease https://ClinicalTrials.gov/show/NCT02559713 Completed Takeda 2019-02-22
NCT03398148 A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy https://ClinicalTrials.gov/show/NCT03398148 Recruiting AbbVie 2022-03-09
NCT03398135 A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis Who Responded to Induction Treatment in M16-067 or M16-065 https://ClinicalTrials.gov/show/NCT03398135 Recruiting AbbVie 2022-12-04
NCT02550418 Budesonide 9 mg Capsules in Active UC https://ClinicalTrials.gov/show/NCT02550418 Completed Dr. Falk Pharma GmbH 2017-03-31
NCT02550158 A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02550158 Completed Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2014-11-30
NCT02543021 Virtual Chromoendoscopy for Colitis Surveillance: A Feasibility Study https://ClinicalTrials.gov/show/NCT02543021 Completed King’s College Hospital NHS Trust 2017-11-01
NCT02537210 Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02537210 Recruiting Chinese University of Hong Kong 2021-09-30
NCT02536404 Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02536404 Completed Arena Pharmaceuticals 2018-11-01
NCT02522780 Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02522780 Completed Ferring Pharmaceuticals 2018-09-19
NCT02516384 Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02516384 Completed Weill Medical College of Cornell University 2016-12-31
NCT03594708 Immunonutrition in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03594708 Recruiting Baptist Memorial Health Care Corporation 2018-12-31
NCT02497469 An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02497469 Completed Takeda 2018-09-26
NCT02493712 A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M https://ClinicalTrials.gov/show/NCT02493712 Completed Holy Stone Healthcare Co., Ltd 2018-07-31
NCT02487238 Pediatric FEcal Microbiota Transplant for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02487238 Completed McMaster Children’s Hospital 2018-12-31
NCT02469103 The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02469103 Completed Chinese University of Hong Kong 2018-01-31
NCT02463045 Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects https://ClinicalTrials.gov/show/NCT02463045 Completed Topivert Pharma Ltd 2016-07-31
NCT02447302 Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02447302 Completed Arena Pharmaceuticals 2018-02-14
NCT02435992 Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02435992 Active, not recruiting Celgene 2020-03-27
NCT02426372 Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02426372 Completed Qu Biologics Inc. 2016-12-31
NCT02425865 Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET https://ClinicalTrials.gov/show/NCT02425865 Recruiting Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2020-09-30
NCT02425852 A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis https://ClinicalTrials.gov/show/NCT02425852 Recruiting Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2020-12-31
NCT02423460 Threonine Requirement in IBD Adults and Healthy Adult Controls https://ClinicalTrials.gov/show/NCT02423460 Completed Nestlé 2018-09-17
NCT02421705 Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome) https://ClinicalTrials.gov/show/NCT02421705 Recruiting KU Leuven 2099-01-31
NCT02407236 A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02407236 Active, not recruiting Janssen Research & Development, LLC 2018-08-10
NCT02390726 Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02390726 Active, not recruiting University of Vermont 2017-12-31
NCT02368717 An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase https://ClinicalTrials.gov/show/NCT02368717 Completed Ferring Pharmaceuticals 2017-01-05
NCT02370056 Evaluation of 3D Visualization for Total Colectomy https://ClinicalTrials.gov/show/NCT02370056 Completed The Cleveland Clinic 2019-05-17
NCT02345733 Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02345733 Recruiting Wolfson Medical Center 2020-12-31
NCT02337608 Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02337608 Completed Galapagos NV 2015-09-30
NCT02330653 Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02330653 Completed Boston Children’s Hospital 2019-04-08
NCT02322307 Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life https://ClinicalTrials.gov/show/NCT02322307 Completed Icahn School of Medicine at Mount Sinai 2020-01-20
NCT02319798 Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02319798 Completed Manchester University NHS Foundation Trust 2013-07-31
NCT02318667 Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022). https://ClinicalTrials.gov/show/NCT02318667 Completed Merck Sharp & Dohme Corp. 2017-06-21
NCT01562314 A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160) https://ClinicalTrials.gov/show/NCT01562314 Completed GW Research Ltd 2014-08-05
NCT02303132 Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis https://ClinicalTrials.gov/show/NCT02303132 Completed Maastricht University Medical Center 2016-06-30
NCT02306785 TP0502-Pharmaco-Scintigraphic-Study and Amendment https://ClinicalTrials.gov/show/NCT02306785 Completed Tillotts Pharma AG 2013-02-28
NCT02289417 Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02289417 Completed Amgen 2017-09-25
NCT02280629 Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) https://ClinicalTrials.gov/show/NCT02280629 Completed Dr. Falk Pharma GmbH 2018-10-05
NCT02277223 Curcumin in Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02277223 Recruiting Schneider Children’s Medical Center, Israel 2022-07-31
NCT02267694 Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02267694 Completed UConn Health 2015-10-05
NCT00694980 A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00694980 Completed Genentech, Inc. 2011-09-30
NCT02246361 Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication https://ClinicalTrials.gov/show/NCT02246361 Completed Floralis 2015-05-31
NCT02227342 Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02227342 Completed University of Alberta 2016-12-31
NCT02213835 Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02213835 Completed Seattle Children’s Hospital 2017-09-30
NCT02200445 Low Dose IL-2 for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02200445 Recruiting Boston Children’s Hospital 2020-06-30
NCT04074590 Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04074590 Recruiting Novartis 2021-12-13
NCT02171429 A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2) https://ClinicalTrials.gov/show/NCT02171429 Completed Hoffmann-La Roche 2020-03-02
NCT02165215 A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors https://ClinicalTrials.gov/show/NCT02165215 Completed Hoffmann-La Roche 2020-04-06
NCT02155335 Preference for a Prefilled Syringe or Smartjectâ„¢ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) https://ClinicalTrials.gov/show/NCT02155335 Completed Merck Sharp & Dohme Corp. 2015-10-05
NCT02148640 The NOR-SWITCH Study https://ClinicalTrials.gov/show/NCT02148640 Completed Diakonhjemmet Hospital 2016-06-30
NCT02142634 Budesonide for Induction of Remission in Incomplete Microscopic Colitis https://ClinicalTrials.gov/show/NCT02142634 Active, not recruiting Dr. Falk Pharma GmbH 2020-02-29
NCT02138318 High Definition Versus Chromoendoscopy for Dysplasia Detection in Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02138318 Completed The Leeds Teaching Hospitals NHS Trust 2015-09-19
NCT02136069 A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors https://ClinicalTrials.gov/show/NCT02136069 Active, not recruiting Hoffmann-La Roche 2020-04-27
NCT02129439 Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT02129439 Completed Sterna Biologicals GmbH & Co. KG 2017-06-22
NCT02120391 Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application https://ClinicalTrials.gov/show/NCT02120391 Completed University of Wisconsin, Madison 2017-06-30
NCT02118584 Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies https://ClinicalTrials.gov/show/NCT02118584 Recruiting Hoffmann-La Roche 2025-08-16
NCT02108821 Fecal Microbiota Transplantation in Pediatric Patients https://ClinicalTrials.gov/show/NCT02108821 Completed Children’s Mercy Hospital Kansas City 2017-05-30
NCT02093780 Personalized “Alberta” Diet for Prevention of Relapse in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02093780 Completed University of Alberta 2017-10-31
NCT02093767 Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02093767 Completed University of Alberta 2010-09-30
NCT02093663 Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02093663 Completed Shire 2018-11-28
NCT02092285 Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) https://ClinicalTrials.gov/show/NCT02092285 Completed Merck Sharp & Dohme Corp. 2016-05-25
NCT02085083 Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02085083 Completed Mount Sinai Hospital, Canada 2017-11-30
NCT02084186 Moxibustion for Mild and Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02084186 Completed Shanghai Institute of Acupuncture, Moxibustion and Meridian 2015-12-31
NCT00450086 Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis https://ClinicalTrials.gov/show/NCT00450086 Completed Dr. Falk Pharma GmbH 2011-06-30
NCT01294410 Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01294410 Completed Bristol-Myers Squibb 2012-12-31
NCT01290042 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. https://ClinicalTrials.gov/show/NCT01290042 Completed Amgen 2014-04-30
NCT01287195 Oral OKT3 for the Treatment of Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01287195 Completed Brigham and Women’s Hospital 2013-05-02
NCT01278082 SOIBD Collagenous Colitis Maintenance Study https://ClinicalTrials.gov/show/NCT01278082 Completed Dr. Falk Pharma GmbH 2013-03-31
NCT02049502 FMT in Ulcerative Colitis-Associated Pouchitis https://ClinicalTrials.gov/show/NCT02049502 Completed Emory University 2018-02-01
NCT02039505 Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02039505 Completed Takeda 2018-02-27
NCT04207008 Trial of a Decision Support Intervention for Adolescents and Young Adults With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04207008 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-10-31
NCT02020382 Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT02020382 Completed Assistance Publique - Hôpitaux de Paris 2016-12-31
NCT03653026 A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03653026 Recruiting AbbVie 2021-02-23
NCT01972334 Stool Transplant in Pediatric Patients With Recurring C. Difficile Infection https://ClinicalTrials.gov/show/NCT01972334 Completed MemorialCare Health System 2016-07-31
NCT01971814 Early Serum Infliximab Levels in Severe Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT01971814 Completed University of California, San Francisco 2015-01-31
NCT01959282 A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01959282 Completed Janssen Research & Development, LLC 2015-05-20
NCT01959165 MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT01959165 Completed AstraZeneca 2015-08-11
NCT01947101 Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children https://ClinicalTrials.gov/show/NCT01947101 Completed Baylor College of Medicine 2014-12-31
NCT01900574 A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01900574 Active, not recruiting Janssen Research & Development, LLC 2015-02-18
NCT01896635 Faecal Microbiota Transplantation in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01896635 Completed The University of New South Wales 2015-11-30
NCT02025777 Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease https://ClinicalTrials.gov/show/NCT02025777 Completed Medtronic - MITG 2015-06-30
NCT01868373 Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea https://ClinicalTrials.gov/show/NCT01868373 Enrolling by invitation Baylor College of Medicine 2022-02-28
NCT01863771 A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT01863771 Completed Janssen Pharmaceutical K.K. 2016-01-29
NCT01839214 A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01839214 Completed Vascular Biogenics Ltd. operating as VBL Therapeutics 2014-11-30
NCT01837615 Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis https://ClinicalTrials.gov/show/NCT01837615 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2015-05-31
NCT01829321 Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01829321 Completed Galapagos NV 2014-04-30
NCT01813526 Infants With Protein Sensitive Colitis https://ClinicalTrials.gov/show/NCT01813526 Completed Abbott Nutrition 2001-02-28
NCT01790061 Standardized Fecal Microbiota Transplantation for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01790061 Recruiting The Second Hospital of Nanjing Medical University 2022-12-31
NCT04224857 SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101 https://ClinicalTrials.gov/show/NCT04224857 Active, not recruiting Applied Molecular Transport 2020-08-30
NCT01772615 Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle https://ClinicalTrials.gov/show/NCT01772615 Completed Hvidovre University Hospital 2013-08-31
NCT01764542 Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors https://ClinicalTrials.gov/show/NCT01764542 Completed Sahlgrenska University Hospital, Sweden 2015-01-31
NCT01771809 Long-Term Safety Of PF-00547659 In Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01771809 Completed Shire 2017-12-13
NCT01759056 Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01759056 Completed Avaxia Biologics, Incorporated 2013-12-31
NCT01757964 Bacteriotherapy in Pediatric Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01757964 Completed Seattle Children’s Hospital 2013-10-31
NCT01745770 TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT01745770 Completed Dr. Falk Pharma GmbH 2015-03-31
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT01716039 Active, not recruiting Western University, Canada 2019-07-31
NCT01694485 Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01694485 Completed Amgen 2015-07-13
NCT01692743 Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) https://ClinicalTrials.gov/show/NCT01692743 Completed University of Maryland, Baltimore 2015-07-31
NCT01684514 Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of Treatment https://ClinicalTrials.gov/show/NCT01684514 Completed Herlev Hospital 2014-12-31
NCT01670240 Adalimumab in the Treatment of Chronic Pouchitis https://ClinicalTrials.gov/show/NCT01670240 Completed Odense University Hospital 2015-09-30
NCT01647516 Efficacy and Safety Study of RPC1063 in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01647516 Completed Celgene 2015-03-10
NCT02043600 Randomized-controlled Trial of Yoga for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02043600 Completed Universität Duisburg-Essen 2015-05-31
NCT01620255 A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01620255 Completed Shire 2014-09-30
NCT01612039 Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01612039 Completed Telsar Pharma Inc. 2014-04-30
NCT01585155 Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01585155 Completed Mitsubishi Tanabe Pharma Corporation 2014-09-30
NCT03999294 Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03999294 Completed University of Valencia 2016-06-30
NCT01561248 Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis https://ClinicalTrials.gov/show/NCT01561248 Completed Universitätsklinikum Hamburg-Eppendorf 2011-06-30
NCT01551290 A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01551290 Completed Xian-Janssen Pharmaceutical Ltd. 2014-03-31
NCT01551004 Phase I Trial of a Single Dose of CRS3123 https://ClinicalTrials.gov/show/NCT01551004 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2014-04-07
NCT01550965 A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting https://ClinicalTrials.gov/show/NCT01550965 Completed AbbVie 2015-04-30
NCT01545908 Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01545908 Completed Hamilton Health Sciences Corporation 2014-08-31
NCT01536535 Predicting Response to Standardized Pediatric Colitis Therapy https://ClinicalTrials.gov/show/NCT01536535 Completed Connecticut Children’s Medical Center 2018-04-30
NCT01536509 Improving Medication Adherence in Pediatric Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01536509 Completed Children’s Hospital Medical Center, Cincinnati 2016-05-31
NCT01534312 Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) https://ClinicalTrials.gov/show/NCT01534312 Completed University of Aarhus 2014-09-30
NCT01532648 Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) https://ClinicalTrials.gov/show/NCT01532648 Completed Bausch Health Americas, Inc. 2013-10-02
NCT01506362 Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01506362 Completed BioLineRx, Ltd. 2013-05-31
NCT01505842 Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01505842 Active, not recruiting Karolinska University Hospital 2019-04-04
NCT01493960 The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT01493960 Completed InDex Pharmaceuticals 2013-06-30
NCT01482884 Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01482884 Completed AstraZeneca 2013-03-31
NCT01481142 Adacolumn in Refractory UC Patients Trial https://ClinicalTrials.gov/show/NCT01481142 Completed Otsuka Pharmaceutical Europe Ltd 2015-05-31
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. https://ClinicalTrials.gov/show/NCT01477320 Completed University of Louisville 2016-07-31
NCT01470612 Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01470612 Active, not recruiting Pfizer 2020-07-27
NCT01461317 Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01461317 Completed Genentech, Inc. 2016-08-07
NCT01458951 A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01458951 Completed Pfizer 2015-05-31
NCT01458574 A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01458574 Completed Pfizer 2016-05-27
NCT01456052 A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01456052 Completed Lexicon Pharmaceuticals 2013-09-03
NCT01453491 A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01453491 Completed GlaxoSmithKline 2013-03-18
NCT01433471 Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova https://ClinicalTrials.gov/show/NCT01433471 Completed NYU Langone Health 2015-05-31
NCT03189888 Granulocyte-monocyte Apheresis in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03189888 Completed Valduce Hospital 2013-12-31
NCT01418131 Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis https://ClinicalTrials.gov/show/NCT01418131 Completed The University of Western Australia 2016-09-30
NCT03832400 Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03832400 Recruiting NuBiyota 2019-11-30
NCT01408810 Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01408810 Completed Grupo de Estudo da Doença Inflamatória Intestinal 2012-11-30
NCT01393405 Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01393405 Completed University of North Carolina, Chapel Hill 2017-04-30
NCT01387594 Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn’s Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs https://ClinicalTrials.gov/show/NCT01387594 Completed Shire 2014-03-31
NCT01369355 A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn’s Disease (IM-UNITI) https://ClinicalTrials.gov/show/NCT01369355 Completed Janssen Research & Development, LLC 2015-06-10
NCT01369342 A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease (UNITI-2) https://ClinicalTrials.gov/show/NCT01369342 Completed Janssen Research & Development, LLC 2014-08-31
NCT01346826 Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT01346826 Completed Asan Medical Center 2015-10-31
NCT01341808 Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients https://ClinicalTrials.gov/show/NCT01341808 Completed Asan Medical Center 2013-02-28
NCT01336465 Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01336465 Completed Genentech, Inc. 2012-09-30
NCT01320436 Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01320436 Completed Sheba Medical Center 2014-09-30
NCT01320332 A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01320332 Completed Telsar Pharma Inc. 2011-08-31
NCT04191655 High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT04191655 Recruiting Beth Israel Deaconess Medical Center 2021-10-31
NCT04340895 Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study) https://ClinicalTrials.gov/show/NCT04340895 Recruiting Ferring Pharmaceuticals 2021-12-31
NCT04329481 The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients https://ClinicalTrials.gov/show/NCT04329481 Recruiting Tel-Aviv Sourasky Medical Center 2022-06-12
NCT04259138 Determination of the Optimal Treatment Target in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04259138 Recruiting Robarts Clinical Trials Inc. 2024-11-30
NCT04254783 A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease https://ClinicalTrials.gov/show/NCT04254783 Recruiting AbbVie 2021-07-02
NCT04241029 Boosting Biologics in UC https://ClinicalTrials.gov/show/NCT04241029 Recruiting Oslo University Hospital 2021-06-30
NCT04237181 Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ER https://ClinicalTrials.gov/show/NCT04237181 Recruiting Assistance Publique - Hôpitaux de Paris 2021-03-15
NCT04223479 Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan https://ClinicalTrials.gov/show/NCT04223479 Recruiting University of Jordan 2021-11-30
NCT04183608 A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab https://ClinicalTrials.gov/show/NCT04183608 Recruiting Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2022-01-31
NCT04209556 A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04209556 Recruiting Pfizer 2023-10-26
NCT04165265 The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy https://ClinicalTrials.gov/show/NCT04165265 Recruiting Nordsjaellands Hospital 2021-06-30
NCT04159311 Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in Remission https://ClinicalTrials.gov/show/NCT04159311 Recruiting Clinique Paris-Bercy 2021-11-02
NCT04147598 Diet Study on Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04147598 Completed University of Miami 2018-09-11
NCT04143633 Low FODMAP Diet on Nutritional Status, Disease Activity and Gut Microbiota in IBS and UC With Normal or Overweight BMI https://ClinicalTrials.gov/show/NCT04143633 Recruiting Hospital General de Mexico 2020-08-31
NCT04143490 Effects of Exercise in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04143490 Recruiting Manchester Metropolitan University 2020-09-30
NCT04133194 Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04133194 Recruiting Copenhagen University Hospital, Hvidovre 2022-09-30
NCT04130919 Study to Evaluate the Efficacy and Safety of GS-4875 in Adults With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04130919 Recruiting Gilead Sciences 2021-04-30
NCT04114292 TUDCA as a Therapy for Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT04114292 Recruiting Washington University School of Medicine 2020-12-31
NCT04057547 Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat Syndrome https://ClinicalTrials.gov/show/NCT04057547 Recruiting Xiyuan Hospital of China Academy of Chinese Medical Sciences 2019-07-01
NCT04043897 Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis https://ClinicalTrials.gov/show/NCT04043897 Recruiting NorthShore University HealthSystem 2020-04-30
NCT04030676 QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04030676 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2021-01-31
NCT04023396 Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04023396 Recruiting Abivax S.A. 2021-11-30
NCT04018040 Vegetarian Diet in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04018040 Recruiting Edith Cowan University 2021-12-31
NCT04013152 Clinical Database of Colorectal Robotic Surgery https://ClinicalTrials.gov/show/NCT04013152 Recruiting Institut du Cancer de Montpellier - Val d’Aurelle 2021-01-31
NCT04006080 Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04006080 Recruiting Guy’s and St Thomas’ NHS Foundation Trust 2020-03-31
NCT04003818 Efficacy and Safety of Teicoplanin in CDAD https://ClinicalTrials.gov/show/NCT04003818 Recruiting Sanofi 2022-04-30
NCT04000139 Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04000139 Recruiting University of Zurich 2020-11-30
NCT03998488 Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03998488 Active, not recruiting Weill Medical College of Cornell University 2023-01-31
NCT03948919 Low Sulfur Fecal Transplant for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03948919 Recruiting University of Minnesota 2020-12-31
NCT03943550 Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Patients With Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03943550 Recruiting Hoffmann-La Roche 2021-04-07
NCT03934216 Safety and Efficacy of BMS-986165 in Subjects With Moderate to Severe Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03934216 Recruiting Bristol-Myers Squibb 2021-08-16
NCT03923478 ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03923478 Recruiting Assembly Biosciences 2021-06-30
NCT03917095 The Safety and Efficacy of TET Enema in the Treatment of UC https://ClinicalTrials.gov/show/NCT03917095 Recruiting The Second Hospital of Nanjing Medical University 2019-06-15
NCT03915769 To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03915769 Recruiting Celgene 2021-07-23
NCT03912714 COlonic Salvage by Therapeutic Appendectomy. https://ClinicalTrials.gov/show/NCT03912714 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2020-09-30
NCT03908073 Electrical Vagal Nerve Stimulation in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03908073 Recruiting Queen Mary University of London 2020-06-15
NCT03893565 Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03893565 Recruiting GlaxoSmithKline 2022-04-19
NCT03885713 Identification of Predictive Biomarkers for Response to Biologic Therapies in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03885713 Recruiting Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 2021-08-31
NCT03104036 Faecal Bacteriotherapy for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03104036 Recruiting Institute for Clinical and Experimental Medicine 2020-06-30
NCT03863886 Endoscopic Ultrasound Determines Disease Activity in Crohn’s Disease And Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03863886 Recruiting Carilion Clinic 2020-01-31
NCT03861143 Efficacy and Safety of Oral BT-11 in Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03861143 Recruiting Landos Biopharma Inc. 2020-06-30
NCT03860896 GB004 in Adult Subjects With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03860896 Completed Gossamer Bio Inc. 2019-12-17
NCT03849599 A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03849599 Completed Provention Bio, Inc. 2019-03-01
NCT03844932 A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03844932 Recruiting Sublimity Therapeutics Holdco Limited 2020-11-30
NCT03804931 Fecal Microbiota Transplantation for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03804931 Recruiting Guangzhou First People’s Hospital 2028-12-31
NCT03800420 Efficacy and Safety of BBT-401-1S in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03800420 Active, not recruiting Bridge Biotherapeutics, Inc. 2020-05-18
NCT03798210 Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03798210 Recruiting Uppsala University 2019-01-31
NCT03781284 PET Combined With MRI for Monitoring Inflammatory Activity in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03781284 Completed Universität Duisburg-Essen 2018-10-31
NCT03006068 A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03006068 Enrolling by invitation AbbVie 2022-01-07
NCT03768219 Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03768219 Active, not recruiting Aptevo Therapeutics 2020-09-30
NCT03760003 Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03760003 Recruiting Abivax S.A. 2020-06-30
NCT03759041 A Study to Assess Efficacy and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03759041 Recruiting Seres Therapeutics, Inc. 2020-07-31
NCT03756454 Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery. https://ClinicalTrials.gov/show/NCT03756454 Recruiting Ohio State University 2021-07-31
NCT03724929 Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03724929 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2021-09-30
NCT03724175 The Role of Secondary Bile Acids in Intestinal Inflammation https://ClinicalTrials.gov/show/NCT03724175 Recruiting Stanford University 2025-12-31
NCT03720002 HF2 Therapy in the Treatment of Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03720002 Recruiting Sheba Medical Center 2021-01-31
NCT03773952 Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT03773952 Recruiting Palobiofarma SL 2020-06-30
NCT03716388 Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC https://ClinicalTrials.gov/show/NCT03716388 Recruiting Dayanand Medical College and Hospital 2019-12-01
NCT03711006 The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03711006 Completed Aleris-Hamlet Hospitaler København 2017-11-30
NCT03705117 Open-label V565 Target Engagement Study https://ClinicalTrials.gov/show/NCT03705117 Completed VHsquared Ltd. 2017-10-24
NCT03698500 Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03698500 Recruiting University Hospital Muenster 2020-12-31
NCT03695185 A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy https://ClinicalTrials.gov/show/NCT03695185 Recruiting AbbVie 2020-12-18
NCT03679546 EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis https://ClinicalTrials.gov/show/NCT03679546 Recruiting Rennes University Hospital 2021-01-04
NCT03675477 A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT03675477 Recruiting Reistone Biopharma Company Limited 2020-07-31
NCT03656627 Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease https://ClinicalTrials.gov/show/NCT03656627 Recruiting Alliance Foundation Trials, LLC. 2022-10-31
NCT02291523 The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02291523 Recruiting Children’s Hospital Los Angeles 2021-11-30
NCT03609905 Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03609905 Recruiting Liaocheng People’s Hospital 2019-02-01
NCT03601611 Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms https://ClinicalTrials.gov/show/NCT03601611 Completed Herlev Hospital 2020-01-28
NCT03587519 Short or Long Interval to Ileostomy Reversal After Ileal Pouch Surgery https://ClinicalTrials.gov/show/NCT03587519 Enrolling by invitation University of Colorado, Denver 2021-01-01
NCT03582969 Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT03582969 Recruiting Assaf-Harofeh Medical Center 2021-07-31
NCT03581149 Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT03581149 Recruiting American University of Beirut Medical Center 2020-07-26
NCT03565939 Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO) https://ClinicalTrials.gov/show/NCT03565939 Recruiting ParaTech A/S 2021-12-31
NCT03561532 Fecal Transplantation in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03561532 Active, not recruiting Joint Authority for Päijät-Häme Social and Health Care 2020-05-31
NCT03538366 Fecal Microbiota Transplantation for Chronic Pouchitis https://ClinicalTrials.gov/show/NCT03538366 Completed Aalborg University Hospital 2019-05-01
NCT03536988 TAMIS-IPAA vs. Lap-IPAA for Ulcerative Colitiis https://ClinicalTrials.gov/show/NCT03536988 Recruiting Jinling Hospital, China 2020-09-01
NCT03531892 A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03531892 Recruiting Eisai Inc. 2020-11-30
NCT03494764 Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares https://ClinicalTrials.gov/show/NCT03494764 Active, not recruiting Dartmouth-Hitchcock Medical Center 2020-09-01
NCT03483246 Impact of Fecal Microbiota Transplantation in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03483246 Recruiting Assistance Publique - Hôpitaux de Paris 2021-09-30
NCT03478956 A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn’s Disease https://ClinicalTrials.gov/show/NCT03478956 Active, not recruiting Hoffmann-La Roche 2019-12-02
NCT03441893 Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03441893 Active, not recruiting Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan 2025-07-01
NCT03427229 Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection https://ClinicalTrials.gov/show/NCT03427229 Completed Catholic University of the Sacred Heart 2017-10-30
NCT03412682 To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03412682 Completed Ferring Pharmaceuticals 2020-05-11
NCT01257399 Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase https://ClinicalTrials.gov/show/NCT01257399 Completed Tillotts Pharma AG 2013-01-31
NCT01257386 Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01257386 Completed Tillotts Pharma AG 2012-08-31
NCT01245465 Profermin® in Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01245465 Completed Nordisk Rebalance A/S 2009-11-30
NCT01240915 A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01240915 Completed Pfizer 2014-11-30
NCT01209208 Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis https://ClinicalTrials.gov/show/NCT01209208 Completed Dr. Falk Pharma GmbH 2017-06-30
NCT01201122 Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01201122 Completed Wolfson Medical Center 2015-12-31
NCT01193894 Trial on Profermin and Fresubin in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01193894 Completed Nordisk Rebalance A/S 2012-09-30
NCT01177228 Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01177228 Completed Millennium Pharmaceuticals, Inc. 2008-06-30
NCT01149707 Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01149707 Completed PurGenesis Technologies Inc. 2014-10-01
NCT01149694 A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers https://ClinicalTrials.gov/show/NCT01149694 Completed PurGenesis Technologies Inc. 2009-08-31
NCT01130844 Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01130844 Completed Shire 2013-06-30
NCT01124149 Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01124149 Completed Shire 2012-12-07
NCT01100112 (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets https://ClinicalTrials.gov/show/NCT01100112 Completed Bausch Health Americas, Inc. 2010-07-31
NCT01097590 A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01097590 Completed IBD Column Therapies International AB 2011-10-31
NCT01090154 Study of Cimzia for the Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01090154 Active, not recruiting University of Washington 2019-12-31
NCT01065571 Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity https://ClinicalTrials.gov/show/NCT01065571 Completed University of Illinois at Chicago 2013-12-31
NCT01059344 Efficacy and Safety of Asacolâ„¢ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01059344 Completed Tillotts Pharma AG 2011-07-31
NCT01037322 Cannabidiol for Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01037322 Completed Meir Medical Center 2012-09-30
NCT01033305 Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyColâ„¢) https://ClinicalTrials.gov/show/NCT01033305 Completed Sigmoid Pharma 2011-08-31
NCT01026857 Propionyl-L-Carnitine in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01026857 Completed sigma-tau i.f.r. S.p.A. 2009-04-30
NCT01020708 Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01020708 Completed Altheus Therapeutics, Inc. 2010-09-30
NCT00963287 Trial of Chinese Prescription on Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00963287 Completed Shanghai University of Traditional Chinese Medicine 2011-07-31
NCT00951548 Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00951548 Completed VSL Pharmaceuticals NA
NCT00952952 Trial of Mesalamine for the Treatment of Active Microscopic Colitis https://ClinicalTrials.gov/show/NCT00952952 Completed Mayo Clinic 2007-11-30
NCT00940576 Dietetic Efficacy of Mare’s Milk for Patients With Chronic Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT00940576 Completed University of Jena 2001-02-28
NCT00928681 A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00928681 Completed Pfizer 2008-04-30
NCT00922103 A Study to Investigate the Ileo Neo Rectal Anastomosis Compared to the Ileo Pouch Anal Anastomosis for Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00922103 Completed Elisabeth-TweeSteden Ziekenhuis 2009-12-31
NCT03869905 Aquamin® as an Adjuvant Intervention for Ulcerative Colitis In Remission https://ClinicalTrials.gov/show/NCT03869905 Recruiting University of Michigan 2022-12-31
NCT00853099 A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00853099 Completed AbbVie 2011-05-31
NCT04102852 Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients https://ClinicalTrials.gov/show/NCT04102852 Recruiting San Giovanni Addolorata Hospital 2020-09-30
NCT02127398 Stool Transplants to Treat Refractory Clostridium Difficile Colitis https://ClinicalTrials.gov/show/NCT02127398 Recruiting Duke University 2022-05-31
NCT02033408 Manipulating the Microbiome in IBD by Antibiotics and FMT https://ClinicalTrials.gov/show/NCT02033408 Active, not recruiting Shaare Zedek Medical Center 2018-12-31
NCT01804166 A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn’s Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) https://ClinicalTrials.gov/show/NCT01804166 Completed Janssen Scientific Affairs, LLC 2020-02-29
NCT01491997 Mind-Body Medicine and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01491997 Completed Rush University Medical Center 2017-07-31
NCT03794765 Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03794765 Completed Postgraduate Institute of Medical Education and Research 2020-03-04
NCT03232528 The Promotion Plan of Moxibustion on Ulcerate Colitis https://ClinicalTrials.gov/show/NCT03232528 Recruiting Shanghai Institute of Acupuncture, Moxibustion and Meridian 2018-12-30
NCT02921555 Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02921555 Recruiting Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 2019-11-30
NCT02445365 Remote Ischemic Conditioning in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02445365 Completed Odense University Hospital 2018-02-28
NCT01988961 A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01988961 Completed Janssen Research & Development, LLC 2015-02-28
NCT01284062 Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT01284062 Completed Pfizer 2013-04-30
NCT00829595 Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00829595 Completed Cedars-Sinai Medical Center 2007-12-31
NCT00810030 FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR https://ClinicalTrials.gov/show/NCT00810030 Completed Vifor (International) Inc. 2009-12-31
NCT00808977 A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00808977 Completed Palau Pharma S.A. 2010-06-30
NCT01860651 Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01860651 Completed Hvidovre University Hospital 2017-05-31
NCT01520324 Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy https://ClinicalTrials.gov/show/NCT01520324 Completed CosmoTech 2012-07-31
NCT03558152 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03558152 Recruiting Genentech, Inc. 2021-08-11
NCT00803829 Synbiotic Treatment of Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT00803829 Completed University of Dundee 2011-01-31
NCT00801723 (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT00801723 Completed Bausch Health Americas, Inc. 2011-05-31
NCT03368118 Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03368118 Active, not recruiting Abivax S.A. 2019-03-08
NCT03100864 This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients https://ClinicalTrials.gov/show/NCT03100864 Completed Boehringer Ingelheim 2019-08-05
NCT03018054 Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03018054 Completed Eisai Inc. 2019-04-17
NCT03273465 Fecal Microbiota Transplantation in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03273465 Recruiting Assaf-Harofeh Medical Center 2020-04-30
NCT03123120 A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy https://ClinicalTrials.gov/show/NCT03123120 Active, not recruiting Boehringer Ingelheim 2020-03-26
NCT03053713 The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03053713 Enrolling by invitation University of British Columbia 2020-04-01
NCT02943538 Telemedicine Crohn’s Disease and Ulcerative Colitis (TECCU) https://ClinicalTrials.gov/show/NCT02943538 Completed Instituto de Investigacion Sanitaria La Fe 2016-12-31
NCT02865707 Ulcerative Colitis Relapse Prevention by Prebiotics https://ClinicalTrials.gov/show/NCT02865707 Recruiting University of Alberta 2020-02-29
NCT02065622 Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02065622 Completed AbbVie 2019-09-05
NCT02818686 TD-1473 for Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02818686 Completed Theravance Biopharma 2018-03-31
NCT03758443 Efficacy & Safety of TD-1473 in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03758443 Recruiting Theravance Biopharma 2025-06-30
NCT02601300 An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02601300 Completed Celgene 2016-09-06
NCT02745678 Localized Therapeutics for the Treatment of Gastrointestinal Disorders II https://ClinicalTrials.gov/show/NCT02745678 Completed Stanford University 2017-11-30
NCT03977480 Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03977480 Recruiting Tianjin Hemay Pharmaceutical Co.,Ltd 2020-12-31
NCT02522767 Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02522767 Completed Ferring Pharmaceuticals 2018-02-06
NCT02508012 Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT02508012 Active, not recruiting University Hospital, Montpellier 2020-09-23
NCT01903252 TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT01903252 Completed Tillotts Pharma AG 2016-05-31
NCT01831427 Evaluating the Safety, Pharmacokinetics and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01831427 Completed Gilead Sciences 2015-02-06
NCT00867438 Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy https://ClinicalTrials.gov/show/NCT00867438 Completed CosmoTech 2007-11-30
NCT01650038 Transplantation of Faeces in Ulcerative Colitis; Restoring Nature’s Homeostasis https://ClinicalTrials.gov/show/NCT01650038 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2014-08-31
NCT01929668 Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients https://ClinicalTrials.gov/show/NCT01929668 Completed Kyungpook National University Hospital 2014-12-31
NCT03650413 An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn’s Disease https://ClinicalTrials.gov/show/NCT03650413 Recruiting Genentech, Inc. 2022-12-17
NCT02469220 Diet Treatment of Patients With Ulcerative Colitis in Remission https://ClinicalTrials.gov/show/NCT02469220 Active, not recruiting Vendsyssel Hospital 2020-07-31
NCT00783718 Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00783718 Completed Millennium Pharmaceuticals, Inc. 2011-12-31
NCT00790933 An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT00790933 Completed Takeda 2017-10-31
NCT00787202 A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT00787202 Completed Pfizer 2010-09-30
NCT00781638 ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00781638 Completed Otsuka Frankfurt Research Institute GmbH 2012-03-31
NCT00746447 Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT00746447 Completed Dr. Falk Pharma GmbH 2007-04-30
NCT00767728 Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00767728 Completed Bausch Health Americas, Inc. 2007-08-31
NCT00747110 Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT00747110 Completed Dr. Falk Pharma GmbH 2008-08-31
NCT00744016 Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00744016 Completed Bausch Health Americas, Inc. 2007-05-31
NCT00737789 Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT00737789 Completed Ferring Pharmaceuticals 2010-06-30
NCT00729872 A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00729872 Completed ActoGeniX N.V. 2009-09-30
NCT00727324 Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00727324 Completed AM-Pharma 2006-11-30
NCT00718094 Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00718094 Completed University of Louisville 2011-10-31
NCT00713310 Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00713310 Completed Warner Chilcott 2011-03-31
NCT00708656 The Colitis Once Daily Asacol Study https://ClinicalTrials.gov/show/NCT00708656 Completed Cardiff and Vale University Health Board 2010-07-31
NCT00679432 (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMXâ„¢) 6 mg and 9 mg in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00679432 Completed Bausch Health Americas, Inc. 2010-05-31
NCT00679380 (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMXâ„¢) 6 mg and 9 mg in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00679380 Completed Bausch Health Americas, Inc. 2010-02-28
NCT00679003 Managing Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00679003 Completed University of Washington 2014-03-31
NCT00659802 Phase II Study of HMPL-004 in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00659802 Completed Hutchison Medipharma Limited 2009-10-31
NCT02065557 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02065557 Completed AbbVie 2020-02-07
NCT00656890 A Study of MDX-1100 in Subjects With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00656890 Completed Bristol-Myers Squibb 2009-09-30
NCT00643071 Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT00643071 Completed Astellas Pharma Inc 2008-05-31
NCT00620126 The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00620126 Completed University of Maryland, Baltimore 2010-02-28
NCT00619489 Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT00619489 Completed Millennium Pharmaceuticals, Inc. 2010-03-31
NCT00616434 A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00616434 Completed Biogen 2010-03-31
NCT00603733 Canadian Active & Maintenance Modified Pentasa Study https://ClinicalTrials.gov/show/NCT00603733 Completed Ferring Pharmaceuticals 2011-05-31
NCT00586599 Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn’s Disease and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00586599 Completed Indiana University 2014-06-30
NCT00586352 Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00586352 Completed Indiana University 2011-11-30
NCT00577473 Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) https://ClinicalTrials.gov/show/NCT00577473 Completed Warner Chilcott 2003-02-28
NCT00573794 Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00573794 Completed AbbVie 2016-12-31
NCT00572585 Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00572585 Completed Novartis 2012-04-30
NCT00568256 Mind/Body Medicine and IBD Flare-Up https://ClinicalTrials.gov/show/NCT00568256 Completed Rush University Medical Center 2011-01-31
NCT00548574 Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00548574 Completed Shire NA
NCT00545389 Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 https://ClinicalTrials.gov/show/NCT00545389 Completed Shire NA
NCT00542152 Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00542152 Completed Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2007-06-30
NCT00521950 Cost-effectiveness of TPMT Pharmacogenetics https://ClinicalTrials.gov/show/NCT00521950 Completed Radboud University 2011-12-31
NCT00533078 Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT00533078 Completed University Hospital Inselspital, Berne 2009-12-31
NCT00505778 A Comparison of Once a Day Dose Compared to 2 Doses/Day https://ClinicalTrials.gov/show/NCT00505778 Completed Warner Chilcott 2009-07-31
NCT00503243 Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00503243 Completed Shire NA
NCT00498589 Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00498589 Completed Centre Hospitalier Universitaire de Besancon 2014-02-28
NCT00490048 Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum https://ClinicalTrials.gov/show/NCT00490048 Completed Hillel Yaffe Medical Center NA
NCT00488631 An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00488631 Completed Janssen Research & Development, LLC 2011-10-31
NCT00486031 Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT00486031 Completed Bausch Health Americas, Inc. 2008-04-30
NCT00463151 An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00463151 Completed Otsuka Pharmaceutical Co., Ltd. 2009-02-28
NCT00449722 OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00449722 Completed Dr. Falk Pharma GmbH NA
NCT00446849 Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT00446849 Completed Shire 2009-07-31
NCT00430898 Basiliximab in Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00430898 Completed Cerimon Pharmaceuticals 2008-09-30
NCT00421642 Open-Label Adalimumab for Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT00421642 Completed Mayo Clinic 2008-04-30
NCT00417872 Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis https://ClinicalTrials.gov/show/NCT00417872 Completed Romark Laboratories L.C. NA
NCT00410410 A Study of Abatacept in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00410410 Completed Bristol-Myers Squibb 2009-06-30
NCT00409396 A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease https://ClinicalTrials.gov/show/NCT00409396 Completed Vanderbilt University 2007-11-30
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00408629 Completed Abbott 2010-03-31
NCT00408174 Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00408174 Completed Bausch Health Americas, Inc. 2007-07-31
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00385736 Completed Abbott 2009-04-30
NCT00382304 A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea https://ClinicalTrials.gov/show/NCT00382304 Completed Sanofi NA
NCT00374725 Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. https://ClinicalTrials.gov/show/NCT00374725 Completed Odense University Hospital NA
NCT00352404 Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia https://ClinicalTrials.gov/show/NCT00352404 Completed Johannes Gutenberg University Mainz NA
NCT00350415 A Double Blind Study for the Treatment of Acute Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00350415 Completed Warner Chilcott 2007-05-31
NCT00347048 Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT00347048 Completed Astellas Pharma Inc 2008-04-30
NCT00343850 Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00343850 Completed University of Chicago 2007-03-31
NCT00326209 Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission https://ClinicalTrials.gov/show/NCT00326209 Completed Bausch Health Americas, Inc. 2008-05-05
NCT00304356 Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection https://ClinicalTrials.gov/show/NCT00304356 Completed VA Medical Center, Houston 2007-01-31
NCT00303381 Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00303381 Completed EMD Serono 2003-01-31
NCT00299013 Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00299013 Completed Alizyme 2008-04-30
NCT00295282 A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00295282 Completed Bristol-Myers Squibb 2008-01-31
NCT00269438 New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00269438 Completed Bausch Health Americas, Inc. 2007-03-31
NCT00267306 Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00267306 Completed Facet Biotech 2006-12-31
NCT00261118 Rituximab in Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00261118 Completed Royal Liverpool University Hospital 2009-08-31
NCT00259558 Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis https://ClinicalTrials.gov/show/NCT00259558 Completed Heidelberg University NA
NCT00259545 Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00259545 Completed Heidelberg University NA
NCT00232258 Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study https://ClinicalTrials.gov/show/NCT00232258 Completed Sanofi 2006-09-30
NCT00219414 Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) https://ClinicalTrials.gov/show/NCT00219414 Completed Otsuka Frankfurt Research Institute GmbH NA
NCT00209300 Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission https://ClinicalTrials.gov/show/NCT00209300 Completed Ferring Pharmaceuticals 2007-05-31
NCT00194818 Asacol Dosing Study for Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00194818 Completed University of Washington 2007-08-31
NCT00180076 Budesonide for Maintenance Treatment of Collagenous Colitis https://ClinicalTrials.gov/show/NCT00180076 Completed Technische Universität Dresden 2007-03-31
NCT00180050 Budesonide Treatment for Lymphocytic Colitis https://ClinicalTrials.gov/show/NCT00180050 Completed Technische Universität Dresden 2006-08-31
NCT00167882 The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels https://ClinicalTrials.gov/show/NCT00167882 Completed VU University Medical Center NA
NCT00151944 Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT00151944 Completed Shire NA
NCT00151892 Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00151892 Completed Shire 2009-09-30
NCT00145808 Wireless Capsule Endoscopy in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00145808 Completed University of Chicago 2007-06-30
NCT00145015 FishGastro Study: Fish Consumption and Gastro-Intestinal Health https://ClinicalTrials.gov/show/NCT00145015 Completed Quadram Institute Bioscience NA
NCT00798642 Ulcerative Colitis Relapse Prevention Trial, Hypnosis https://ClinicalTrials.gov/show/NCT00798642 Completed Northwestern University 2011-11-30
NCT00106509 A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea https://ClinicalTrials.gov/show/NCT00106509 Completed Sanofi NA
NCT00102193 Study for the Treatment of Ulcerative Colitis With Adacolumn https://ClinicalTrials.gov/show/NCT00102193 Completed Otsuka America Pharmaceutical 2006-07-31
NCT00096655 A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00096655 Completed Centocor, Inc. NA
NCT00092508 CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission https://ClinicalTrials.gov/show/NCT00092508 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. NA
NCT00073047 Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00073047 Completed Facet Biotech NA
NCT00073021 Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00073021 Completed Warner Chilcott 2003-09-30
NCT00072943 A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn’s Disease https://ClinicalTrials.gov/show/NCT00072943 Completed Facet Biotech 2004-04-30
NCT00065065 A Trial of Rosiglitazone for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00065065 Completed University of Pennsylvania 2008-01-31
NCT00064454 FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00064454 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2006-07-31
NCT00064441 FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00064441 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2006-05-31
NCT00063830 ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis. https://ClinicalTrials.gov/show/NCT00063830 Completed Ionis Pharmaceuticals, Inc. NA
NCT00063414 ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00063414 Completed Ionis Pharmaceuticals, Inc. NA
NCT00048347 Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00048347 Completed National Institutes of Health Clinical Center (CC) 2008-06-30
NCT00036439 A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00036439 Completed Centocor, Inc. NA
NCT00034294 A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea https://ClinicalTrials.gov/show/NCT00034294 Completed Sanofi NA
NCT00033943 Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00033943 Completed Incara Pharmaceuticals NA
NCT00032305 Research Study in Patients With Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00032305 Completed Facet Biotech 2005-11-30
NCT00676832 Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00676832 Completed Prometheus Laboratories 2009-10-31
NCT00652145 Dose Escalation and Remission (DEAR) https://ClinicalTrials.gov/show/NCT00652145 Completed University of Pennsylvania 2013-01-31
NCT00628433 Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00628433 Completed Harbor Therapeutics 2009-05-31
NCT00002273 A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS https://ClinicalTrials.gov/show/NCT00002273 Completed NIH AIDS Clinical Trials Information Service NA
NCT00000768 A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients https://ClinicalTrials.gov/show/NCT00000768 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00720538 Thalidomide in Pediatric Inflammatory Bowel Diseases. https://ClinicalTrials.gov/show/NCT00720538 Completed IRCCS Burlo Garofolo 2011-09-30
NCT00487539 An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00487539 Completed Janssen Research & Development, LLC 2010-10-31
NCT00366925 CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00366925 Completed Otsuka Frankfurt Research Institute GmbH 2008-02-29
NCT00355602 Antibiotics for the Treatment of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00355602 Completed University of Dundee 2008-12-31
NCT00004810 Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00004810 Completed Office of Rare Diseases (ORD) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03090139 Sub-optimal Response to Anti-Tumor Necrosis Factor’s in Inflammatory Bowel Disease in Emerging Markets https://ClinicalTrials.gov/show/NCT03090139 Completed Takeda 2018-06-13
NCT00001184 Immune Regulation in Ulcerative Colitis or Crohn s Disease https://ClinicalTrials.gov/show/NCT00001184 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03689673 Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03689673 Active, not recruiting Ipsen 2020-12-31
NCT01078324 Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding https://ClinicalTrials.gov/show/NCT01078324 Completed University of California, Los Angeles 2009-12-31
NCT03824561 Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] https://ClinicalTrials.gov/show/NCT03824561 Recruiting Takeda 2022-01-31
NCT03262025 Primary Cecal Pathologies Presenting as Acute Abdomen https://ClinicalTrials.gov/show/NCT03262025 Completed Jawaharlal Nehru Medical College 2017-05-31
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service https://ClinicalTrials.gov/show/NCT03223012 Completed AbbVie 2019-02-28
NCT03179865 Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03179865 Completed Wolfson Medical Center 2020-02-29
NCT03143517 Fecal Calprotectin Collection Protocol https://ClinicalTrials.gov/show/NCT03143517 Completed DiaSorin Inc. 2018-08-23
NCT03142113 Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03142113 Completed Universitaire Ziekenhuizen Leuven 2016-12-31
NCT03063957 Identification/Characterization of Changes in Microscopic Colitis https://ClinicalTrials.gov/show/NCT03063957 Recruiting Massachusetts General Hospital 2023-07-31
NCT02897271 Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort https://ClinicalTrials.gov/show/NCT02897271 Active, not recruiting Children’s Hospital Medical Center, Cincinnati 2019-09-30
NCT02868398 Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab https://ClinicalTrials.gov/show/NCT02868398 Completed Evangelismos Hospital 2020-04-30
NCT02808780 An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02808780 Recruiting Janssen Biotech, Inc. 2031-07-30
NCT02750800 Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) https://ClinicalTrials.gov/show/NCT02750800 Completed AbbVie 2018-04-03
NCT02717897 Vitamin D and Disease Activity in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02717897 Completed University of Chicago 2013-05-31
NCT02709213 Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy https://ClinicalTrials.gov/show/NCT02709213 Completed University Hospital, Geneva 2019-12-31
NCT02699333 Risk Factors for Microscopic Colitis https://ClinicalTrials.gov/show/NCT02699333 Recruiting University of North Carolina, Chapel Hill 2020-12-31
NCT02693730 Phenotyping IBS: Perceptions and Modulations of Visceral Sensations https://ClinicalTrials.gov/show/NCT02693730 Active, not recruiting University of California, Los Angeles 2020-08-31
NCT01916161 The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients https://ClinicalTrials.gov/show/NCT01916161 Completed National Health Service, United Kingdom 2016-02-29
NCT02674308 Entyvio (Vedolizumab) Long Term Safety Study https://ClinicalTrials.gov/show/NCT02674308 Active, not recruiting Takeda 2021-07-22
NCT02640391 Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02640391 Completed Kyungpook National University Hospital 2018-12-31
NCT02600143 Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy. https://ClinicalTrials.gov/show/NCT02600143 Completed University Medical Center Groningen 2019-04-30
NCT02586259 Effectiveness of Cortiment® in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02586259 Completed Ferring Pharmaceuticals 2018-04-05
NCT03404557 Proteomic Analysis of Crohn’s Disease Macrophages in Response or Not to AIEC https://ClinicalTrials.gov/show/NCT03404557 Completed University Hospital, Clermont-Ferrand 2019-01-18
NCT02738125 Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions https://ClinicalTrials.gov/show/NCT02738125 Active, not recruiting AbbVie 2028-11-20
NCT02506179 Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02506179 Completed AbbVie 2020-02-10
NCT02502552 Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort https://ClinicalTrials.gov/show/NCT02502552 Completed Centre Hospitalier Universitaire de Saint Etienne 2015-10-31
NCT02499263 A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02499263 Completed AbbVie 2018-09-17
NCT02439372 Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02439372 Completed Asan Medical Center 2016-06-30
NCT02438410 Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02438410 Completed Mayo Clinic 2019-12-04
NCT02274714 Dysmenorrhea in Women With Crohn’s Disease and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02274714 Completed University of Wisconsin, Madison 2017-01-31
NCT02261636 Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment https://ClinicalTrials.gov/show/NCT02261636 Completed Ferring Pharmaceuticals 2019-01-14
NCT02229344 Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea https://ClinicalTrials.gov/show/NCT02229344 Active, not recruiting Janssen Korea, Ltd., Korea 2022-02-22
NCT02170714 Efficacy of Infliximab as a Rescue Therapy in Pediatric Acute Severe Colitis https://ClinicalTrials.gov/show/NCT02170714 Completed University of Roma La Sapienza 2012-05-31
NCT02149043 Thermography in Surveillance of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02149043 Completed University Hospital Dubrava 2018-01-31
NCT02110862 Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02110862 Completed Odense University Hospital 2013-08-31
NCT01301976 Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01301976 Completed UPECLIN HC FM Botucatu Unesp 2010-03-31
NCT01282905 Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01282905 Completed KU Leuven NA
NCT02054533 Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02054533 Completed Icahn School of Medicine at Mount Sinai 2017-06-30
NCT01966744 Self-Management Assistance for Recommended Treatment (SMART) Portal https://ClinicalTrials.gov/show/NCT01966744 Completed Children’s Hospital Medical Center, Cincinnati 2016-06-30
NCT01960439 Responsiveness of Endoscopic Evaluation in UC https://ClinicalTrials.gov/show/NCT01960439 Completed University of Western Ontario, Canada 2015-07-31
NCT01947816 Special Investigation in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01947816 Completed AbbVie 2018-02-15
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01930032 Pathogenic Mechanisms in C Diff Infection and Colitis https://ClinicalTrials.gov/show/NCT01930032 Completed Beth Israel Deaconess Medical Center 2014-01-31
NCT01928667 Case-Control Study to Identify Risk Factors for Microscopic Colitis https://ClinicalTrials.gov/show/NCT01928667 Completed Maastricht University Medical Center 2016-06-30
NCT01891214 Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT01891214 Completed Rennes University Hospital 2016-04-30
NCT01852760 Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound https://ClinicalTrials.gov/show/NCT01852760 Completed Lawson Health Research Institute 2015-07-31
NCT01848561 A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT01848561 Recruiting AbbVie 2027-04-06
NCT01798953 Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis https://ClinicalTrials.gov/show/NCT01798953 Completed Sahlgrenska University Hospital, Sweden 2013-02-28
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01768858 Completed AbbVie 2017-08-13
NCT01740349 Evaluation Of The Pillcamâ„¢ Colon Capsule Endoscopy (Pcce-2) In Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01740349 Completed Azienda Policlinico Umberto I 2012-09-30
NCT01705522 Multimodal Approach in IBD Patients https://ClinicalTrials.gov/show/NCT01705522 Recruiting Clinical Hospital Colentina 2019-09-30
NCT01678300 Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) https://ClinicalTrials.gov/show/NCT01678300 Completed Beth Israel Deaconess Medical Center 2015-11-30
NCT01654783 Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA https://ClinicalTrials.gov/show/NCT01654783 Completed Kyorin Pharmaceutical Co.,Ltd 2014-06-30
NCT01604564 Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients https://ClinicalTrials.gov/show/NCT01604564 Active, not recruiting Universitaire Ziekenhuizen Leuven 2019-12-31
NCT01517607 Mesalazine (PENTASA®) in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01517607 Completed Ferring Pharmaceuticals 2013-12-31
NCT01517594 Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01517594 Completed Ferring Pharmaceuticals 2013-06-30
NCT01468090 Disease Course in an IBD Cohort in the Era of Biological Treatment https://ClinicalTrials.gov/show/NCT01468090 Completed Hvidovre University Hospital 2014-06-30
NCT01467609 PillCam Colon Capsule Endoscopy for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01467609 Completed Shanghai Jiao Tong University School of Medicine 2010-07-31
NCT01387698 Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01387698 Completed Ferring Pharmaceuticals 2015-10-31
NCT01363453 User Surveillance in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01363453 Completed Ferring Pharmaceuticals 2008-05-31
NCT01326013 A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel https://ClinicalTrials.gov/show/NCT01326013 Completed Luminex Molecular Diagnostics 2012-02-29
NCT04411784 PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04411784 Active, not recruiting Hull University Teaching Hospitals NHS Trust 2020-07-31
NCT00463619 Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00463619 Completed Heidelberg University 2010-04-30
NCT04279821 Prevalence of Segmental Colitis Associated With Colic Diverticulosis (SCAD) https://ClinicalTrials.gov/show/NCT04279821 Recruiting University of Roma La Sapienza 2021-02-01
NCT04272307 MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach. https://ClinicalTrials.gov/show/NCT04272307 Recruiting University Hospital, Bordeaux 2021-02-28
NCT04197973 Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients https://ClinicalTrials.gov/show/NCT04197973 Recruiting Keimyung University Dongsan Medical Center 2020-06-20
NCT04148274 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04148274 Recruiting ProgenaBiome 2023-03-31
NCT03952364 The PRECIOUS Study: Predicting Crohn’s & ColitIs Outcomes in the United States https://ClinicalTrials.gov/show/NCT03952364 Recruiting PredictImmune Ltd 2021-06-30
NCT03952195 Complications and Outcomes of Pouch Excision https://ClinicalTrials.gov/show/NCT03952195 Completed Icahn School of Medicine at Mount Sinai 2017-04-01
NCT03947931 Russian Extremely Severe Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT03947931 Recruiting State Scientific Centre of Coloproctology, Russian Federation 2021-06-20
NCT03942861 Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol. https://ClinicalTrials.gov/show/NCT03942861 Recruiting Copenhagen University Hospital at Herlev 2020-08-21
NCT03907631 Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC) https://ClinicalTrials.gov/show/NCT03907631 Recruiting Hull University Teaching Hospitals NHS Trust 2020-09-01
NCT03884439 Infliximab Biosimilar “Pfizer” Drug Use Investigation (Crohn’s Disease or Ulcerative Colitis) https://ClinicalTrials.gov/show/NCT03884439 Recruiting Pfizer 2023-03-13
NCT03839680 Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03839680 Recruiting Centre Hospitalier Universitaire de Besancon 2019-04-15
NCT03808506 Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03808506 Recruiting Lawson Health Research Institute 2021-06-30
NCT03802214 Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy https://ClinicalTrials.gov/show/NCT03802214 Recruiting Stanford University 2021-12-31
NCT03788824 Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE https://ClinicalTrials.gov/show/NCT03788824 Recruiting Shandong University 2018-12-31
NCT02523118 OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages https://ClinicalTrials.gov/show/NCT02523118 Recruiting Children’s Hospital Medical Center, Cincinnati 2050-12-31
NCT03773445 Golimumab Trough Levels in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03773445 Recruiting Hospital San Carlos, Madrid 2019-10-31
NCT03765450 Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03765450 Recruiting Robarts Clinical Trials Inc. 2019-12-31
NCT03747068 The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. https://ClinicalTrials.gov/show/NCT03747068 Completed HaEmek Medical Center, Israel 2015-10-09
NCT03698812 A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03698812 Recruiting Nanfang Hospital of Southern Medical University 2020-09-30
NCT03669822 Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) https://ClinicalTrials.gov/show/NCT03669822 Recruiting Johns Hopkins University 2020-12-31
NCT03549988 Pro-active Fecal Calprotectin Monitoring PROMOTE-UC https://ClinicalTrials.gov/show/NCT03549988 Recruiting University of British Columbia 2020-06-30
NCT03589183 Gut Microbiome in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03589183 Recruiting Kyunghee University Medical Center 2028-03-31
NCT03535649 A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants https://ClinicalTrials.gov/show/NCT03535649 Completed Takeda 2018-12-18
NCT03501758 Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound https://ClinicalTrials.gov/show/NCT03501758 Recruiting Haukeland University Hospital 2023-12-30
NCT03477032 FMT in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03477032 Recruiting St Vincent’s Hospital Melbourne 2019-12-31
NCT03460847 Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa https://ClinicalTrials.gov/show/NCT03460847 Recruiting Medical University of Graz 2020-03-31
NCT03452501 Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients https://ClinicalTrials.gov/show/NCT03452501 Active, not recruiting Hikma Pharmaceuticals LLC 2020-06-30
NCT00304408 Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody https://ClinicalTrials.gov/show/NCT00304408 Completed VA Medical Center, Houston 2008-01-31
NCT01169207 Johns Hopkins Crohn’s Disease and Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT01169207 Active, not recruiting Johns Hopkins University 2020-12-31
NCT01104753 A Study of Pentasa in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01104753 Completed Ferring Pharmaceuticals 2010-10-31
NCT01091558 Study of Effects of L-Arginine in Colitis and Colon Cancer https://ClinicalTrials.gov/show/NCT01091558 Completed Vanderbilt University Medical Center 2011-12-31
NCT01058356 Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea https://ClinicalTrials.gov/show/NCT01058356 Completed Pharmbio Korea Co., Ltd. 2010-01-31
NCT01032525 Monroe County Inflammatory Bowel Disease (IBD) Registry https://ClinicalTrials.gov/show/NCT01032525 Completed University of Rochester 2013-05-31
NCT00961948 Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00961948 Completed Mayo Clinic 2013-02-28
NCT00917514 An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen https://ClinicalTrials.gov/show/NCT00917514 Completed Medicpen AB 2010-02-28
NCT03643211 Xeljanz Special Investigation for Long-term Use in UC Patients https://ClinicalTrials.gov/show/NCT03643211 Active, not recruiting Pfizer 2022-01-05
NCT03282903 The PRognostic Effect of Environmental Factors in Crohn’s and Colitis https://ClinicalTrials.gov/show/NCT03282903 Recruiting University of Edinburgh 2020-10-31
NCT02799615 Anti-TNF Therapy for Refractory Colitis in Hospitalized Children https://ClinicalTrials.gov/show/NCT02799615 Completed Children’s Hospital Medical Center, Cincinnati 2019-02-11
NCT04131530 Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence https://ClinicalTrials.gov/show/NCT04131530 Recruiting Shandong University 2019-12-31
NCT03578692 Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC) https://ClinicalTrials.gov/show/NCT03578692 Completed Nanjing PLA General Hospital 2018-01-31
NCT03397108 Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03397108 Recruiting The Hospital for Sick Children 2020-07-31
NCT02986724 A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) https://ClinicalTrials.gov/show/NCT02986724 Active, not recruiting Takeda 2020-08-31
NCT02423512 The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness https://ClinicalTrials.gov/show/NCT02423512 Completed Icahn School of Medicine at Mount Sinai 2017-06-13
NCT03710486 A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn’s Disease (CD) Participants https://ClinicalTrials.gov/show/NCT03710486 Recruiting Takeda 2021-09-30
NCT00780507 Fecal Biomarker Study for Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00780507 Completed Warner Chilcott 2009-07-31
NCT00705484 European Safety Registry in Ulcerative Colitis (P04808) https://ClinicalTrials.gov/show/NCT00705484 Completed Merck Sharp & Dohme Corp. 2016-10-20
NCT00617227 Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin https://ClinicalTrials.gov/show/NCT00617227 Completed Maimonides Medical Center 2008-05-31
NCT00604422 Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00604422 Completed Medtronic - MITG 2010-02-28
NCT00587236 Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis https://ClinicalTrials.gov/show/NCT00587236 Completed Mayo Clinic 2010-08-31
NCT00474097 Follow-Up Phone Calls After Colorectal Surgery https://ClinicalTrials.gov/show/NCT00474097 Completed University Hospitals Cleveland Medical Center 2007-12-31
NCT00403923 Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00403923 Completed University Hospitals, Leicester 2007-06-30
NCT00304889 Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis https://ClinicalTrials.gov/show/NCT00304889 Completed VA Medical Center, Houston 2008-01-31
NCT00304876 Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea https://ClinicalTrials.gov/show/NCT00304876 Completed VA Medical Center, Houston 2007-01-31
NCT00304369 Response of Clostridium Difficile Infection to Metronidazole Therapy https://ClinicalTrials.gov/show/NCT00304369 Completed VA Medical Center, Houston 2007-06-30
NCT00274209 Chromoendoscopy for Ulcerative Colitis Surveillance https://ClinicalTrials.gov/show/NCT00274209 Completed Indiana University 2011-11-30
NCT00272818 Study to Identify Non-Invasive Markers of Gastrointestinal Allergy https://ClinicalTrials.gov/show/NCT00272818 Completed Boston Children’s Hospital 2008-06-30
NCT00267475 Data Bank for Eosinophilic Disorders https://ClinicalTrials.gov/show/NCT00267475 Completed Children’s Hospital Medical Center, Cincinnati 2012-12-31
NCT00207688 A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT00207688 Completed Janssen Research & Development, LLC 2015-09-09
NCT00222378 Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00222378 Completed University of Miami 2012-06-30
NCT00606346 A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00606346 Active, not recruiting Janssen Biotech, Inc. 2037-11-15

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03824418 The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03824418 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-05-09
NCT02503514 Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort https://ClinicalTrials.gov/show/NCT02503514 Completed University of North Carolina, Chapel Hill 2017-08-31
NCT03251118 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03251118 Recruiting Target PharmaSolutions, Inc. 2025-07-31
NCT03096717 Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing https://ClinicalTrials.gov/show/NCT03096717 Recruiting Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 2020-05-30
NCT02326155 To Evaluate the Safety and Efficacy of Remsimaâ„¢ in Patients With Crohn’s Disease (CD) or Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02326155 Recruiting Celltrion 2020-06-30
NCT02308917 Canadian Children Inflammatory Bowel Disease Network (CIDsCANN) https://ClinicalTrials.gov/show/NCT02308917 Recruiting The Hospital for Sick Children 2023-12-31
NCT02130349 IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. https://ClinicalTrials.gov/show/NCT02130349 Recruiting Maastricht University Medical Center 2020-12-31
NCT02063282 The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers https://ClinicalTrials.gov/show/NCT02063282 Completed Shaare Zedek Medical Center 2014-12-31
NCT04032756 Tofacitinib Registry of Patients With Ulcerative Colitis in Germany https://ClinicalTrials.gov/show/NCT04032756 Recruiting Ced Service GmbH 2023-03-31
NCT03872726 Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03872726 Recruiting Corporacion Parc Tauli 2019-05-30
NCT03772145 Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study https://ClinicalTrials.gov/show/NCT03772145 Enrolling by invitation University of North Carolina, Chapel Hill 2020-12-31